153 related articles for article (PubMed ID: 31748960)
1. HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer.
Lázaro-Sánchez AD; Salces-Ortiz P; Velásquez LI; Orozco-Beltrán D; Díaz-Fernández N; Juárez-Marroquí A
Clin Transl Oncol; 2020 Jul; 22(7):1166-1171. PubMed ID: 31748960
[TBL] [Abstract][Full Text] [Related]
2. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
3. Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer.
Li JB; Ruan YY; Hu B; Dong SS; Bi TN; Lin A; Yan WH
Oncotarget; 2017 Jul; 8(30):48854-48862. PubMed ID: 28415627
[TBL] [Abstract][Full Text] [Related]
4. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
5. Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study.
Fainardi E; Bortolotti D; Castellazzi M; Casetta I; Bellini T; Rizzo R
Hum Immunol; 2020 Apr; 81(4):156-161. PubMed ID: 31735441
[TBL] [Abstract][Full Text] [Related]
6. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer.
Farjadian S; Tabebordbar M; Mokhtari M; Safaei A; Malekzadeh M; Ghaderi A
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2731-2735. PubMed ID: 30360598
[TBL] [Abstract][Full Text] [Related]
7. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases.
Zhu CB; Wang CX; Zhang X; Zhang J; Li W
Int J Cancer; 2011 Feb; 128(3):617-22. PubMed ID: 20473865
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
[TBL] [Abstract][Full Text] [Related]
10. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
[TBL] [Abstract][Full Text] [Related]
11. HLA-G and anti-HCV in patients on the waiting list for kidney transplantation.
Sommese L; Paolillo R; Cacciatore F; Grimaldi V; Sabia C; Esposito A; Sorriento A; Iannone C; Rupealta N; Sarno G; Santangelo M; De Rosa P; Nicoletti G; Napoli C
Adv Med Sci; 2018 Sep; 63(2):317-322. PubMed ID: 30015095
[TBL] [Abstract][Full Text] [Related]
12. Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma.
Agnihotri V; Gupta A; Kumar L; Dey S
Sci Rep; 2020 Mar; 10(1):3806. PubMed ID: 32123232
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of high circulating sHLA-G in ovarian carcinoma.
Babay W; Boujelbene N; Ben Yahia H; Bortolotti D; Zemni I; Ouzari HI; Chelbi H; Mezlini A; Rizzo R; Zidi I
HLA; 2021 Oct; 98(4):357-365. PubMed ID: 34272932
[TBL] [Abstract][Full Text] [Related]
14. Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
Ben Amor A; Beauchemin K; Faucher MC; Hamzaoui A; Hamzaoui K; Roger M
PLoS One; 2016; 11(8):e0161210. PubMed ID: 27517300
[TBL] [Abstract][Full Text] [Related]
15. Increased plasmatic soluble HLA-G levels in endometrial cancer.
Ben Yahia H; Babay W; Bortolotti D; Boujelbene N; Laaribi AB; Zidi N; Kehila M; Chelbi H; Boudabous A; Mrad K; Mezlini A; Di Luca D; Ouzari HI; Rizzo R; Zidi I
Mol Immunol; 2018 Jul; 99():82-86. PubMed ID: 29730546
[TBL] [Abstract][Full Text] [Related]
16. Association between HLA-G 14bp Gene Polymorphism and Serum sHLA-G Protein Concentrations in Preeclamptic Patients and Normal Pregnant Women.
Rokhafrooz S; Ghadiri A; Ghandil P; Ghafourian M; Hossaini SH; Daraei N; Najafian M; Rouhizadeh A
Immunol Invest; 2018 Aug; 47(6):558-568. PubMed ID: 29952661
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
18. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
20. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
